Evidence map›Paper›PMID 41594627›Full record

ReviewBiomolecules2026

Enhancer Trajectories in Lineage Commitment: Regulatory Logic of States and Cooperation.

Myunggeun Oh, Seunghwa Jeong, Keunsoo Kang, Seung-Kyoon Kim

Abstract readReview
In one paragraph

Review in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Myunggeun OhDepartment of Convergent Bioscience and Informatics, and Graduate School of Biological Sciences, Chungnam National University, Daejeon 34134, Republic of Korea.ORCID 0009-0002-7835-221X
Seunghwa JeongDepartment of Convergent Bioscience and Informatics, and Graduate School of Biological Sciences, Chungnam National University, Daejeon 34134, Republic of Korea.ORCID 0009-0008-4749-1595
Keunsoo KangDepartment of Biomedical Sciences, Dankook University, Cheonan 31116, Republic of Korea.ORCID 0000-0003-0611-9320
Seung-Kyoon KimDepartment of Convergent Bioscience and Informatics, and Graduate School of Biological Sciences, Chungnam National University, Daejeon 34134, Republic of Korea.ORCID 0000-0001-9776-4047

Funding

National Research Foundation of Korea 2022R1A2C1093041National Research Foundation of Korea RS-2023-00209842National Research Foundation of Korea RS-2025-02305916
6 · The paper itself

Abstract

Cell fate determination depends on precise and timely control of gene expression programs governed by enhancers, which act as central regulatory elements within chromatin landscapes. Recent studies reveal that enhancers occupy distinct functional states, including poised, primed, and active configurations, and that these states dynamically transition during lineage specification. These transitions, in turn, coordinate chromatin accessibility and transcriptional competence, establishing when and how developmental genes become activated. Beyond individual enhancers, some fate-defining loci employ modular and shadow enhancer architectures that cooperatively regulate transcriptional dose, maintain threshold stability, and buffer developmental programs against stochastic and environmental variation. Comparative analyses across neural, cardiac, and hematopoietic systems illustrate how these enhancer modules are selectively deployed to achieve lineage-specific precision and robustness. Furthermore, enhancer timing, persistence, and quantitative thresholds collectively encode developmental tempo and stability, ensuring faithful progression of cell fate transitions. By considering molecular state transitions together with cooperative enhancer architecture, this review organizes current views on how enhancers may help translate transient cues into stable lineage outcomes, thereby linking chromatin dynamics to developmental precision.

Indexed as

Cell LineageEnhancer Elements, GeneticAnimalsCell DifferentiationChromatinGene Expression Regulation, DevelopmentalHumansChromatinchromatindevelopmental robustnessenhancerenhancer state transitionlineage commitmentmultiple enhancer architecture

Identifiers

PMID41594627
PMCPMC12839130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.